Literature DB >> 29560059

Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease.

David M Cline1, Susan Silva2, Caroline E Freiermuth3, Victoria Thornton3, Paula Tanabe2,3,4.   

Abstract

INTRODUCTION: Use of alternative venues to manage uncomplicated vaso-occlusive crisis (VOC), such as a day hospital (DH) or ED observation unit, for patients with sickle cell anemia, may significantly reduce admission rates, which may subsequently reduce 30-day readmission rates.
METHODS: In the context of a two-institution quality improvement project to implement best practices for management of patients with sickle cell disease (SCD) VOC, we prospectively compared acute care encounters for utilization of 1) emergency department (ED); 2) ED observation unit; 3) DH, and 4) hospital admission, of two different patient cohorts with SCD presenting to our two study sites. Using a representative sample of patients from each institution, we also tabulated SCD patient visits or admissions to outside hospitals within 20 miles of the patients' home institutions.
RESULTS: Over 30 months 427 patients (297 at Site 1 and 130 at Site 2) initiated 4,740 institutional visits, totaling 6,627 different acute care encounters, including combinations of encounters. The range of encounters varied from a low of 0 (203 of 500 patients [40.6%] at Site 1; 65 of 195 patients [33.3%] at Site 2), and a high of 152 (5/month) acute care encounters for one patient at Site 2. Patients at Site 2 were more likely to be admitted to the hospital during the study period (88.4% vs. 74.4%, p=0.0011) and have an ED visit (96.9% vs. 85.5%, p=0.0002). DH was used more frequently at Site 1 (1.207 encounters for 297 patients at Site 1, vs. 199 encounters for 130 patients at Site 2), and ED observation was used at Site 1 only. Thirty-five percent of patients visited hospitals outside their home academic center.
CONCLUSION: In this 30-month assessment of two sickle cell cohorts, healthcare utilization varied dramatically between individual patients. One cohort had more hospital admissions and ED encounters, while the other cohort had more day hospital encounters and used a sickle cell disease observation VOC protocol. One-third of patients sampled visited hospitals for acute care outside of their care providers' institutions.

Entities:  

Mesh:

Year:  2018        PMID: 29560059      PMCID: PMC5851504          DOI: 10.5811/westjem.2017.9.35422

Source DB:  PubMed          Journal:  West J Emerg Med        ISSN: 1936-900X


  26 in total

Review 1.  Evidence-based management of sickle cell disease in the emergency department.

Authors:  Jeffrey Glassberg
Journal:  Emerg Med Pract       Date:  2011-08

2.  Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.

Authors:  Sophie Lanzkron; C Patrick Carroll; Peter Hill; Mandy David; Nicklaine Paul; Carlton Haywood
Journal:  Am J Hematol       Date:  2015-02-25       Impact factor: 10.047

3.  Concentration of hospital care for acute sickle cell disease-related visits.

Authors:  J A Panepinto; P L Owens; A L Mosso; C A Steiner; D C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

4.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

5.  Day-care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere?

Authors:  M A Ware; I Hambleton; I Ochaya; G R Serjeant
Journal:  Br J Haematol       Date:  1999-01       Impact factor: 6.998

6.  Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients.

Authors:  Patricia Houston-Yu; Sohail R Rana; Betsy Beyer; Oswaldo Castro
Journal:  Am J Hematol       Date:  2003-03       Impact factor: 10.047

7.  Quality improvement process in a sickle cell infusion center.

Authors:  Lauren N Whiteman; Sophie Lanzkron; Rosalyn W Stewart; Carlton Haywood; John J Strouse; Leonard Feldman
Journal:  Am J Med       Date:  2014-12-09       Impact factor: 4.965

8.  Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine.

Authors:  Jessica Campos; Clarisse Lobo; Ana Maria Mach Queiroz; Emilia Matos do Nascimento; Carlos Bernardo Lima; Gilberto Cardoso; Samir K Ballas
Journal:  Eur J Haematol       Date:  2014-03-19       Impact factor: 2.997

9.  Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients.

Authors:  Y M Yang; A K Shah; M Watson; V N Mankad
Journal:  Public Health Rep       Date:  1995 Jan-Feb       Impact factor: 2.792

10.  The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Authors:  C Patrick Carroll; Carlton Haywood; Peter Fagan; Sophie Lanzkron
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

View more
  2 in total

1.  Can subjective pain be inferred from objective physiological data? Evidence from patients with sickle cell disease.

Authors:  Mark J Panaggio; Daniel M Abrams; Fan Yang; Tanvi Banerjee; Nirmish R Shah
Journal:  PLoS Comput Biol       Date:  2021-03-11       Impact factor: 4.475

2.  Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study.

Authors:  Amanda Johnson; Fan Yang; Siddharth Gollarahalli; Tanvi Banerjee; Daniel Abrams; Jude Jonassaint; Charles Jonassaint; Nirmish Shah
Journal:  JMIR Mhealth Uhealth       Date:  2019-12-02       Impact factor: 4.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.